Nipah Virus Resurgence in South Asia: Health Authorities Ramp Up Surveillance Amid Fresh Outbreak Fears
Health authorities across South Asia and the broader Indo-Pacific region have elevated their alert levels following confirmed outbreaks of the Nipah virus (NiV) in eastern India. While local officials have moved quickly to quell rumors of a massive surge, the re-emergence of this high-mortality zoonotic pathogen has triggered swift containment protocols and renewed calls for vigilance regarding food safety and wildlife interaction.
Separating Fact from Fiction in West Bengal
Recent reports emerging from West Bengal, India’s fourth most populous state which borders Bangladesh in the east, sparked initial confusion regarding the scale of the infection. Addressing conflicting local narratives, Indian health officials clarified the situation on January 27, 2026. Laboratories have confirmed two cases of Nipah virus infection in the region since December 2025. Authorities emphasized that higher figures circulating on social media stem from unverified preliminary reports.
Despite the low number of confirmed cases, the government remains on high alert. The localized outbreak in West Bengal follows a year of sporadic fatal cases in neighboring Bangladesh—a country that frequently battles NiV outbreaks during seasonal harvesting of date palm sap (a popular sweet-tasting beverage in South Asia). Indian health teams are rigorously tracing contacts of confirmed cases and monitoring border areas to prevent cross-border transmission. As of January 28, at least 196 individuals have been placed under 21-day quarantine due to close contact with confirmed cases.
Understanding the Nipah Threat
The name Nipah virus originates from Sungai Nipah village in the western Malaysian state of Negeri Sembilan, where the first patient from whom the virus was isolated resided. The virus caused an outbreak in Malaysia between September 1998 and May 1999, spreading through infected pigs in pig farms to humans. It resulted in 265 infections and 109 deaths. Additionally, Singapore reported 11 confirmed cases in 1999, including one fatality.
The virus subsequently spread to South Asia, with the first case in Bangladesh reported in 2001. Over the past two decades, outbreaks have occurred multiple times in both India and Bangladesh. Historically, Bangladesh’s outbreaks exhibited distinct seasonality (December to May), primarily linked to fruit bat activity and consumption of raw date palm sap. However, since the first case detected in the southern region in August 2025, the epidemic has shown trends toward year-round persistence and geographic expansion, with cases recorded in over 35 of the country’s 64 districts.
In contrast, India’s past outbreaks were primarily concentrated in the southern state of Kerala. Infection sources were mostly linked to contact with contaminated fruit or person-to-person transmission within hospitals, typically involving small-scale community clusters without prolonged large-scale epidemics. In response, the World Health Organization assesses that Bangladesh, India, and neighboring regions remain at risk of ongoing outbreaks, while the global transmission risk remains low at present.
A Deadly Pathogen Without Approved Cure
Nipah virus is a zoonotic pathogen in the genus Henipavirus under the family Paramyxoviridae. Fruit bats of the family Pteropodidae, particularly species belonging to the Pteropus genus, are the natural hosts for Nipah virus, though they exhibit no apparent symptoms upon infection. The incubation period ranges from 4 to 14 days. However, there has been a case in which the period could reach up to 45 days.
Transmission of the virus usually occurs through direct contact with infected animals, while it can jump to humans through intermediate hosts like pigs or via food sources contaminated by bats. Crucially, human-to-human transmission has been proven possible, typically among family members or caregivers of infected patients.
Once infected, symptoms often begin with fever, headaches, and muscle pain, resembling influenza. However, the infection can rapidly progress to severe encephalitis (inflammation of the brain), leading to disorientation, coma, and death within 24 to 48 hours. Case fatality rates range from 40% to 75%, depending on local epidemiological capabilities and the specific viral strain. In addition, long-term neurological sequelae, such as seizures, overwhelming fatigue and personality changes, afflict nearly 20% of survivors.
Despite the high risks, no globally approved vaccines or specific therapeutics currently exist for the virus. Treatment relies entirely on supportive care which addresses severe respiratory and neurological complications. Nevertheless, the scientific community is making certain progress. The World Health Organization (WHO) identifies NiV as a priority pathogen in its R&D Blueprint due to its epidemic potential and the lack of authorized countermeasures. Also, with the funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the University of Oxford has recently launched the world’s first Phase 2 clinical trial of a NiV vaccine in Bangladesh, marking a critical step toward shielding populations in high-risk regions.
Regional Response and Containment Strategies
The NiV resurgence has prompted immediate preventive measures across several Asian countries and regions, including India and Bangladesh. Health experts in India are focusing on containment zones and enforcing strict isolation protocols for suspected cases to prevent the deadly virus from reaching densely populated urban centers. In Bangladesh, the Institute of Epidemiology, Disease Control and Research (IEDCR) has issued its annual winter warning advising citizens against drinking raw date palm sap. Health officials urge the public to only consume the sap after boiling it, which effectively neutralizes NiV.
Taiwan’s Centers for Disease Control (CDC) recently announced plans to list NiV infection as one of the “Category 5 Communicable Diseases” starting in March 2026. This classification places the virus alongside other severe pathogens like Ebola and MERS. Under this new protocol, medical institutions must report suspected cases within 24 hours and enforce mandatory quarantine measures along with specimen collection to facilitate subsequent epidemiological investigations and containment efforts.
Thailand’s Department of Disease Control (DDC) has reinstated pandemic-level health screenings at major airports in response to the West Bengal outbreak. The intensified protocols for Indian arrivals include thermal scanning and the issuance of “Health Beware Cards” for 21-day symptom monitoring. Authorities have also prepared rapid RT-PCR testing capable of delivering results within eight hours. As of January 28, over 1,700 passengers have been screened, with no confirmed cases detected in the country.
Though remains free of confirmed Nipah cases, Vietnam continues to treat the virus as a Class A infectious disease requiring maximum containment measures. The Hanoi Center for Disease Control (CDC) has ramped up surveillance at Noi Bai International Airport, utilizing thermal scanners to screen travelers from high-risk regions like West Bengal. Health officials have instructed medical facilities to perform immediate epidemiological assessments on symptomatic patients and report findings instantly. To ensure readiness, hospitals are actively securing isolation units, personal protective equipment, and trained personnel for infection control.
Preventive Measures for Travelers
Health experts advise travelers visiting outbreak-prone regions to exercise extreme caution. The primary preventive strategy involves breaking the transmission chain from animals to humans. Key recommendations include:
- Avoid raw sap: Avoid consuming raw date palm sap as this remains the most common transmission route in the Bengal region.
- Food safety: Wash and peel all fruits thoroughly. Discard any fruit that shows signs of bat bites or damage.
- Animal Avoidance: Stay away from bats and pigs, and avoid areas known to be bat roosting sites. Maintain a safe distance from wildlife during visits to zoos or outdoor activities.
- Personal hygiene: Wear masks at all times when visiting local medical facilities. Practice rigorous hand hygiene using soap and water or alcohol-based sanitizers.
- Honest reporting of travel or contact history: In case of symptoms such as fever, headache, sore throat, or confusion within 2 weeks of returning from an outbreak area, seek medical attention immediately and disclose to doctors any recent travel or contact history to facilitate early diagnosis and intervention.







